-
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Given Consensus Rating of "Buy" by Brokerages
Source: Buzz FX / 26 Dec 2024 05:00:12 America/Chicago
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Given Consensus Rating of "Buy" by Brokerages Written by MarketBeat December 26, 2024 Share Link copied to clipboard. SpringWorks Therapeutics, Inc. ( NASDAQ:SWTX - Get Free Report ) has earned a
Read more...